In our study, mRNA level of Cdk2, Cdk4 and Cdk6 down-regulated in MPT0B291-treated glioma cells indicating that HDAC6 inhibitor transcriptionally regulates those cyclin-dependent kinases. Here, HDAC6 is linked to central nervous system cancer.